Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Nasopharyngeal Carcinoma 7Colorectal Neoplasms 4Breast Neoplasms 4Nasopharyngeal Neoplasms 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Sarcoma 2Recurrence 2Neoplasms 2Head and Neck Neoplasms 2Unresectable Non-small Cell Lung Cancer 1Squamous Non-small Cell Lung Cancer 1Squamous Non-Small Cell Lung Cancer SqNSCLC 1Solid Tumors 1Optic Nerve Glioma 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neuroblastoma 1Meningeal Carcinomatosis 1Melanoma 1Lymphoma, T-Cell 1Locally Advanced Squamous Non-small Cell Lung Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Advanced Pancreatic Cancer 1

Interventions

Endostatins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Squamous Non-small Cell Lung Cancer × Endostatins × Clear all
NCT06279754 2024-02-28

Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy

The First Affiliated Hospital of Xinxiang Medical College

Phase 2 Unknown
30 enrolled
Thoracic

Locally Advanced Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡